標(biāo)題: Titlebook: Antiviral Chemotherapy 5; New Directions for C John Mills,Paul A. Volberding,Lawrence Corey Book 1999 The Editor(s) (if applicable) and The [打印本頁] 作者: 投降 時(shí)間: 2025-3-21 18:52
書目名稱Antiviral Chemotherapy 5影響因子(影響力)
作者: 愉快么 時(shí)間: 2025-3-21 21:37 作者: Phonophobia 時(shí)間: 2025-3-22 03:29 作者: 口訣 時(shí)間: 2025-3-22 08:02 作者: 表示向前 時(shí)間: 2025-3-22 11:14 作者: spondylosis 時(shí)間: 2025-3-22 15:48 作者: 心痛 時(shí)間: 2025-3-22 17:02 作者: parallelism 時(shí)間: 2025-3-22 22:44 作者: apropos 時(shí)間: 2025-3-23 03:21 作者: restrain 時(shí)間: 2025-3-23 08:53 作者: 想象 時(shí)間: 2025-3-23 13:24
Book 1999in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in- cubation period of active HIV infection, when the infection is clinically latent, is now un- dersto作者: 異端 時(shí)間: 2025-3-23 16:11 作者: cauda-equina 時(shí)間: 2025-3-23 18:56
https://doi.org/10.1007/978-3-642-97753-4 disease has proven to be a major problem in institutionalized elderly (for example, those living in nursing homes or long-term convalescent hospitals),. and in bone marrow transplant recipients. In the latter group, mortality rates in excess of 50% have been reported..作者: 飛鏢 時(shí)間: 2025-3-23 22:54 作者: 江湖郎中 時(shí)間: 2025-3-24 04:07 作者: APNEA 時(shí)間: 2025-3-24 09:20
0065-2598 evolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in- cubation period of active HIV infection, when the infection is clinically latent, is now 作者: mediocrity 時(shí)間: 2025-3-24 12:44
Mathematical function counters,C) is increased 10 to 390-fold in patients with chronic HBV infection,. and in regions where HBV is endemic, HCC is the leading cause of cancer related deaths. Evolving therapies, discussed in this chapter, may be changing the natural history of HBV infection and even reducing the risk of HCC development.作者: 極大痛苦 時(shí)間: 2025-3-24 15:51
https://doi.org/10.1007/978-3-642-98011-4illion people) are chronic carriers of HBV.. Of chronic carriers, 25–40% of patients will ultimately develop cirrhosis or hepatocellular carcinoma.. The World Health Organization cites hepatitis B as the ninth leading cause of death worldwide..作者: Hypomania 時(shí)間: 2025-3-24 19:07
Properties of Molecular Defects, In addition, drug resistance can develop during therapy and, because the mechanism of action of each of these drugs depends ultimately on inhibition of CMV DNA Polymerase, cross resistance among these drugs can occur. There is a need for safe and effective drugs that are orally bioavailable and directed against novel viral targets.作者: Mere僅僅 時(shí)間: 2025-3-25 00:18
Springer Tracts in Modern Physicsactivation of latent VZV in adults, provide a source of infectious VZV for spread to susceptible contacts. Varicella occurs in a worldwide geographic distribution and causes annual epidemics in temperate climates. These epidemics are less common in tropical areas; as a result, more adults remain susceptible to varicella.作者: 修正案 時(shí)間: 2025-3-25 07:07
Springer Tracts in Modern Physicsnical trial. This chapter will focus on the nucleoside analogue abacavir or 1592U89, the non-nucleoside analogues MKC-442, nevirapine, delavirdine, loviride, efavirenz or DMP 266, and the nucleotide analogues adefovir dipivoxil or bis-pom PMEA, and bis-poc PMPA (Table 1).作者: epinephrine 時(shí)間: 2025-3-25 07:35 作者: GLIDE 時(shí)間: 2025-3-25 11:50 作者: 用樹皮 時(shí)間: 2025-3-25 19:41 作者: 同音 時(shí)間: 2025-3-25 21:30 作者: 一小塊 時(shí)間: 2025-3-26 03:24 作者: 不如樂死去 時(shí)間: 2025-3-26 08:03
Cidofovir,ectrum of herpesviruses, including CMV, HSV-1 and -2, VZV, EBV, HHV-6, HHV-7, and KSHV (HHV-8) [Table 1], as well as against adenovirus, human papillomavirus(HPV), polyomaviruses, and human poxviruses. . Intravenous (IV) cidofovir has been approved in the United States and in Europe as a therapy for CMV retinitis in patients with AIDS.作者: MELON 時(shí)間: 2025-3-26 11:26 作者: Cervical-Spine 時(shí)間: 2025-3-26 16:32
https://doi.org/10.1007/978-1-4615-4743-3HIV; HIV infection; Hepatitis; infection; infections; virus; infectious diseases作者: 許可 時(shí)間: 2025-3-26 17:23 作者: Devastate 時(shí)間: 2025-3-26 23:24 作者: ENACT 時(shí)間: 2025-3-27 02:31 作者: 沙漠 時(shí)間: 2025-3-27 06:16 作者: Migratory 時(shí)間: 2025-3-27 09:36
https://doi.org/10.1007/978-3-642-97753-4sion hepatitis.. Today, in the United States, it is by far the most common cause of chronic viral hepatitis, and is thought to be responsible for approximately 10,000 deaths annually due to chronic liver failure or hepatocellular carcinoma.. Rather than a single virus, HCV is actually a complex of g作者: neutralize 時(shí)間: 2025-3-27 15:33
https://doi.org/10.1007/978-3-642-97753-4 study, it can be estimated that the annual cost of RSV-related illness in the USA is over $300 million per year, and the bulk of this cost is related to hospitalization.. Over the past decade or so it has become apparent that RSV is also a major pathogen of elderly and immunosuppressed adults.. RSV作者: affect 時(shí)間: 2025-3-27 19:29 作者: 不真 時(shí)間: 2025-3-28 00:38
https://doi.org/10.1007/978-3-642-56593-9 cold to neonatal en-teroviral sepsis. The two genuses of classification of picornaviridae are the enteroviridae and rhinoviridae. Rhinoviruses express human parisitization clinically as a naso-pharyngeal syndrome (the “common cold”) which occurs in all populations and age groups and can take up to 作者: faddish 時(shí)間: 2025-3-28 02:56 作者: Complement 時(shí)間: 2025-3-28 10:03
https://doi.org/10.1007/978-3-663-08451-8me structure and the ability to establish lifelong persistent and latent infections after primary exposure.. The basic biology and pathogenesis of CMV disease go beyond the scope of this overview and are reviewed elsewhere.. CMV infection in immunocompromised individuals is acquired exogenously or r作者: 野蠻 時(shí)間: 2025-3-28 14:30 作者: defeatist 時(shí)間: 2025-3-28 16:41
Electronic Defect States in Alkali HalidesOf the three antivirale, only ganciclovir is available in an oral formulation. Studies that have examined the phar-macokinetics of oral ganciclovir indicate that although the peak levels of oral drug when administered at 1000 mg three times daily are considerably less than the standard intravenous d作者: Confound 時(shí)間: 2025-3-28 21:23
Properties of Molecular Defects,iviral activity, but significant toxicities limit their safety and effectiveness, and poor oral bioavailability further limits their clinical utility. In addition, drug resistance can develop during therapy and, because the mechanism of action of each of these drugs depends ultimately on inhibition 作者: 路標(biāo) 時(shí)間: 2025-3-29 02:05
Electronic Defect States in Alkali Halidesyclovir. In general, the clinical significance of acyclovir’s impact on clinical outcomes has been directly proportional to the severity of the natural history of disease. Unfortunately, acyclovir’s limitations are governed by poor oral absorption with a bioavailability of about 15% along with maint作者: 和平 時(shí)間: 2025-3-29 07:07 作者: 傻瓜 時(shí)間: 2025-3-29 08:26
https://doi.org/10.1007/3-540-36422-6 incidence of disease and the resultant morbidity in elderly individuals. The introduction of the prodrugs valaci-clovir and famciclovir for the treatment of herpes zoster has provided significant advances in clinical outcome. In the evaluation of thousands of immunocompetent individuals with herpes作者: 表狀態(tài) 時(shí)間: 2025-3-29 12:59 作者: 中古 時(shí)間: 2025-3-29 18:27
,Ytterbium Ions and CN? Molecules,bitor therapy results in durable, potent suppression of viral replication. Recent data, however, indicates that a significant proportion of patients may not achieve long-term viral suppression.. The prognostic implications of protease inhibitor drug failure, and its clinical management, remain unkno作者: extract 時(shí)間: 2025-3-29 21:31 作者: Prologue 時(shí)間: 2025-3-30 02:15
https://doi.org/10.1007/3-540-36422-6ses to therapy. In the past, the most commonly used tests were CD4 cell counts and serum p24 antigen levels, although serum beta-2 microglobulin, serum neopterin, serum IgA levels and CD8 cell numbers were used as adjunctive measures by some clinicians. Since the early to mid 1990s new technologies 作者: Deadpan 時(shí)間: 2025-3-30 06:03
Antiviral Chemotherapy 5978-1-4615-4743-3Series ISSN 0065-2598 Series E-ISSN 2214-8019 作者: Corral 時(shí)間: 2025-3-30 10:15 作者: 行為 時(shí)間: 2025-3-30 14:30 作者: 除草劑 時(shí)間: 2025-3-30 19:20 作者: 偽造 時(shí)間: 2025-3-30 22:14
Famciclovir Update,ed in a number of countries, including the United States, for the treatment of acute herpes zoster, acute recurrent and primary genital herpes, and suppression of genital herpes recurrences. In addition, ., a topical formulation of penciclovir, has been approved for treatment of herpes labialis cold作者: angina-pectoris 時(shí)間: 2025-3-31 04:18 作者: 牛的細(xì)微差別 時(shí)間: 2025-3-31 09:02 作者: Allure 時(shí)間: 2025-3-31 11:31
Update on Influenza and Rhinovirus Infections,fluenza or rhi-novirus infections in the United States. The only newly approved therapy for symptomatic management of upper respiratory illnesses is topical ipratropium. Intranasal administration of this quaternary anticholinergic reduces colds-associated rhinorrhea to a moderate extent.. However, c作者: 不能根除 時(shí)間: 2025-3-31 16:29 作者: acquisition 時(shí)間: 2025-3-31 20:26 作者: GOAT 時(shí)間: 2025-4-1 00:01
Management of Cytomegalovirus Infections in Blood and Marrow Transplant Recipients,me structure and the ability to establish lifelong persistent and latent infections after primary exposure.. The basic biology and pathogenesis of CMV disease go beyond the scope of this overview and are reviewed elsewhere.. CMV infection in immunocompromised individuals is acquired exogenously or r作者: 埋葬 時(shí)間: 2025-4-1 02:23
Cidofovir,ectrum of herpesviruses, including CMV, HSV-1 and -2, VZV, EBV, HHV-6, HHV-7, and KSHV (HHV-8) [Table 1], as well as against adenovirus, human papillomavirus(HPV), polyomaviruses, and human poxviruses. . Intravenous (IV) cidofovir has been approved in the United States and in Europe as a therapy for
